Reckitt To Pay $1.4B To End US Opioid Probe
British pharmaceutical company Reckitt Benckiser said Thursday it will pay U.S. authorities up to $1.4 billion to settle a long-running investigation into sales of a treatment for addiction to opioids by...To view the full article, register now.
Already a subscriber? Click here to view full article